Assessment of oral Co enzyme Q10 effect on the outcomes in adults patients with Distal Radius fracture

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211228053554N1

Enrollment

Registered

2022-03-22

Start date

2022-06-21

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult distal radius fractures. Adult distal radius fractures

Interventions

Intervention 1: Intervention group: In the intervention group, patients will receive 100 mg of Q-10 daily for 8 weeks. Intervention 2: Control group: patients receiving(placebo of neutral drug)for 8 w

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Adults (age 18 to 40 years old) with distal radius fracture

Exclusion criteria

Exclusion criteria: Patients with intra-articular fractures who require open surgery

Design outcomes

Primary

Measure	Time frame
Duration of the distal radius fracture union. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: Radiography.;Hand grip strength. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: Dynamometer.;Intensity of pain. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: VAS pain score.;Patient performance. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: DASH performance questionnaire.	—

Measure

Time frame

Duration of the distal radius fracture union. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: Radiography.;Hand grip strength. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: Dynamometer.;Intensity of pain. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: VAS pain score.;Patient performance. Timepoint: Before prescribing supplements and in weeks 4 and 8. Method of measurement: DASH performance questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Siamak Kazemi Sufi

Oroumia University of Medical Sciences

Kazemisofi.s@umsu.ac.ir+98 44 3346 9931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026